| 5437- | AG, | Modulation of PD-L1 by Astragalus polysaccharide attenuates the induction of melanoma stem cell properties and overcomes immune evasion |
| - | in-vivo, | Melanoma, | B16-F10 |
| 5436- | AG, | Therapeutic Effect of Astragalus Polysaccharides on Hepatocellular Carcinoma H22-Bearing Mice |
| - | in-vivo, | HCC, | NA |
| 5435- | AG, | Efficacy of Astragalus Membranaceus (Huang Qi) for Cancer-Related Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Studies |
| - | Review, | Var, | NA |
| 5236- | AgNPs, | Adaptive regulations of Nrf2 alleviates silver nanoparticles-induced oxidative stress-related liver cells injury |
| - | in-vitro, | Liver, | HepG2 | - | in-vitro, | Nor, | L02 |
| 5237- | AgNPs, | Nrf2 Activation Mitigates Silver Nanoparticle-Induced Ferroptosis in Hepatocytes |
| - | in-vitro, | Liver, | HepG2 |
| 5238- | AgNPs, | β-Sitosterol-assisted silver nanoparticles activates Nrf2 and triggers mitochondrial apoptosis via oxidative stress in human hepatocellular cancer cell line |
| - | in-vitro, | HCC, | HepG2 |
| 5239- | AgNPs, | NOX4- and Nrf2-mediated oxidative stress induced by silver nanoparticles in vascular endothelial cells |
| - | in-vitro, | Nor, | HUVECs |
| 5975- | AgNPs, | PDT, | CDT, | RF, | Recent Advances in the Application of Silver Nanoparticles for Enhancing Phototherapy Outcomes |
| - | Review, | Var, | NA | - | Review, | BPH, | NA |
| 5976- | AgNPs, | Review on Harnessing Silver Nanoparticles for Therapeutic Innovations: A Comprehensive Review on Medical Applications, Safety, and Future Directions |
| - | Review, | Vit, | NA |
| 5977- | AgNPs, | CDT, | Silver Nitroprusside as an Efficient Chemodynamic Therapeutic Agent and a Peroxynitrite nanogenerator for Targeted Cancer Therapy |
| - | in-vivo, | Ovarian, | A2780S | - | NA, | Ovarian, | SKOV3 |
| 5978- | AgNPs, | Biological synthesis of silver nanoparticles and their medical applications |
| - | Review, | Var, | NA |
| 1406- | AgNPs, | The antioxidant effects of silver, gold, and zinc oxide nanoparticles on male mice in in vivo condition |
| - | in-vivo, | Nor, | NA |
| 1909- | AgNPs, | The Antibacterial Drug Candidate SBC3 is a Potent Inhibitor of Bacterial Thioredoxin Reductase |
| - | in-vivo, | Nor, | NA |
| 1908- | AgNPs, | Exposure to Silver Nanoparticles Inhibits Selenoprotein Synthesis and the Activity of Thioredoxin Reductase |
| - | in-vitro, | Lung, | A549 |
| 1907- | AgNPs, | GoldNP, | Cu, | In vitro antitumour activity of water soluble Cu(I), Ag(I) and Au(I) complexes supported by hydrophilic alkyl phosphine ligands |
| - | in-vitro, | Lung, | A549 | - | in-vitro, | BC, | MCF-7 | - | in-vitro, | Melanoma, | A375 | - | in-vitro, | Colon, | HCT15 | - | in-vitro, | Cerv, | HeLa |
| 1906- | AgNPs, | GoldNP, | Cu, | Current Progresses in Metal-based Anticancer Complexes as Mammalian TrxR Inhibitors |
| - | Review, | Var, | NA |
| 1905- | AgNPs, | Evaluation of the effect of silver and silver nanoparticles on the function of selenoproteins using an in-vitro model of the fish intestine: The cell line RTgutGC |
| - | in-vivo, | Nor, | NA |
| 1903- | AgNPs, | Novel Silver Complexes Based on Phosphanes and Ester Derivatives of Bis(pyrazol-1-yl)acetate Ligands Targeting TrxR: New Promising Chemotherapeutic Tools Relevant to SCLC Managemen |
| - | in-vitro, | Lung, | U1285 |
| 1902- | AgNPs, | Modulation of the mechanism of action of antibacterial silver N-heterocyclic carbene complexes by variation of the halide ligand |
| - | in-vitro, | NA, | NA |
| 1594- | AgNPs, | Citrate, | Silver Citrate Nanoparticles Inhibit PMA-Induced TNFα Expression via Deactivation of NF-κB Activity in Human Cancer Cell-Lines, MCF-7 |
| - | in-vitro, | BC, | MCF-7 |
| 4403- | AgNPs, | Silver Nanoparticles Decorated UiO-66-NH2 Metal-Organic Framework for Combination Therapy in Cancer Treatment |
| - | in-vitro, | GBM, | U251 | - | in-vitro, | GBM, | U87MG | - | in-vitro, | GBM, | GL26 | - | in-vitro, | Cerv, | HeLa | - | in-vitro, | CRC, | RKO |
| 4404- | AgNPs, | Rad, | Main Approaches to Enhance Radiosensitization in Cancer Cells by Nanoparticles: A Systematic Review |
| - | Review, | Var, | NA |
| 4402- | AgNPs, | Enhancement of Triple-Negative Breast Cancer-Specific Induction of Cell Death by Silver Nanoparticles by Combined Treatment with Proteotoxic Stress Response Inhibitors |
| - | in-vitro, | BC, | BT549 | - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | Nor, | MCF10 |
| 4401- | AgNPs, | Rad, | Metformin-loaded chitosan nanoparticles augment silver nanoparticle-induced radiosensitization in breast cancer cells during radiation therapy |
| - | in-vitro, | BC, | NA |
| 4400- | AgNPs, | Rad, | Differential cytotoxic and radiosensitizing effects of silver nanoparticles on triple-negative breast cancer and non-triple-negative breast cells |
| - | in-vitro, | BC, | MCF-7 | - | in-vitro, | Nor, | MCF10 | - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | BC, | BT549 | - | in-vivo, | BC, | MDA-MB-231 |
| 4399- | AgNPs, | Chit, | Silver nanoparticles impregnated alginate-chitosan-blended nanocarrier induces apoptosis in human glioblastoma cells |
| - | in-vitro, | GBM, | U87MG |
| 4398- | AgNPs, | Induction of apoptosis in cancer cells at low silver nanoparticle concentrations using chitosan nanocarrier |
| - | in-vitro, | Colon, | HT29 |
| 4397- | AgNPs, | Synthesis and Characterization of Silver Nanoparticles from Rhizophora apiculata and Studies on Their Wound Healing, Antioxidant, Anti-Inflammatory, and Cytotoxic Activity |
| - | NA, | Wounds, | NA |
| - | in-vitro, | OS, | MG63 |
| 4395- | AgNPs, | Hepatoprotective effect of silver nanoparticles synthesized using aqueous leaf extract of Rhizophora apiculata |
| - | in-vivo, | LiverDam, | NA |
| 4394- | AgNPs, | Silver nanoparticles provoke apoptosis of Dalton's ascites lymphoma in vivo by mitochondria dependent and independent pathways |
| - | in-vivo, | lymphoma, | NA |
| 4393- | AgNPs, | Nanotoxic Effects of Silver Nanoparticles on Normal HEK-293 Cells in Comparison to Cancerous HeLa Cell Line |
| - | in-vitro, | Cerv, | HeLa | - | in-vitro, | Nor, | HEK293 |
| 4392- | AgNPs, | Hepatocurative activity of biosynthesized silver nanoparticles fabricated using Andrographis paniculata |
| - | in-vivo, | LiverDam, | NA |
| 4391- | AgNPs, | Silver Nanoparticles Induce Apoptosis in HepG2 Cells through Particle-Specific Effects on Mitochondria |
| - | NA, | Liver, | HepG2 |
| 4390- | AgNPs, | Therapeutic Potential of Cucumis melo (L.) Fruit Extract and Its Silver Nanopartciles Against DEN-Induced Hepatocellular Cancer in Rats |
| - | in-vivo, | Liver, | NA |
| 4389- | AgNPs, | Graphene Oxide-Silver Nanocomposite Enhances Cytotoxic and Apoptotic Potential of Salinomycin in Human Ovarian Cancer Stem Cells (OvCSCs): A Novel Approach for Cancer Therapy |
| - | in-vitro, | Ovarian, | NA |
| 4388- | AgNPs, | Differential Cytotoxic Potential of Silver Nanoparticles in Human Ovarian Cancer Cells and Ovarian Cancer Stem Cells |
| - | in-vitro, | Cerv, | NA |
| 4387- | AgNPs, | Attenuation of diethylnitrosamine (DEN) - Induced hepatic cancer in experimental model of Wistar rats by Carissa carandas embedded silver nanoparticles |
| - | in-vitro, | Liver, | NA |
| 4386- | AgNPs, | Evaluation of hepatic cancer stem cells (CD73+, CD44+, and CD90+) induced by diethylnitrosamine in male rats and treatment with biologically synthesized silver nanoparticles |
| 4385- | AgNPs, | Hepatoprotective effect of engineered silver nanoparticles coated bioactive compounds against diethylnitrosamine induced hepatocarcinogenesis in experimental mice |
| - | in-vitro, | Liver, | NA |
| 4414- | AgNPs, | Silver nanoparticles: Forging a new frontline in lung cancer therapy |
| - | Review, | Lung, | NA |
| 4423- | AgNPs, | Pongamia pinnata seed extract-mediated green synthesis of silver nanoparticle loaded nanogel for estimation of their antipsoriatic properties |
| - | in-vivo, | PSA, | NA |
| 4422- | AgNPs, | Bioengineering of Piper longum L. extract mediated silver nanoparticles and their potential biomedical applications |
| - | in-vitro, | Cerv, | HeLa |
| 4421- | AgNPs, | Effect of Biologically Synthesized Silver Nanoparticles on Human Cancer Cells |
| - | in-vitro, | Cerv, | NA |
| 4424- | AgNPs, | Understanding the prospective of nano-formulations towards the treatment of psoriasis |
| - | in-vivo, | PSA, | NA |
| 4419- | AgNPs, | Tackling the various classes of nano-therapeutics employed in topical therapy of psoriasis |
| - | NA, | PSA, | NA |
| 4418- | AgNPs, | Nanocarriers for the topical treatment of psoriasis - pathophysiology, conventional treatments, nanotechnology, regulatory and toxicology |
| - | Human, | PSA, | NA |
| 4417- | AgNPs, | Caffeine-boosted silver nanoparticles target breast cancer cells by triggering oxidative stress, inflammation, and apoptotic pathways |
| - | in-vitro, | BC, | MDA-MB-231 |
| 4416- | AgNPs, | Efficacy of curcumin-synthesized silver nanoparticles on MCF-7 breast cancer cells |
| - | in-vitro, | BC, | MCF-7 |
| 4415- | AgNPs, | SDT, | CUR, | Examining the Impact of Sonodynamic Therapy With Ultrasound Wave in the Presence of Curcumin-Coated Silver Nanoparticles on the Apoptosis of MCF7 Breast Cancer Cells |
| - | in-vitro, | BC, | MCF-7 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid